We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: A choose in Texas guidelines 3 different states can problem entry to abortion tablet mifepristone nationwide
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > A choose in Texas guidelines 3 different states can problem entry to abortion tablet mifepristone nationwide
A choose in Texas guidelines 3 different states can problem entry to abortion tablet mifepristone nationwide
Health

A choose in Texas guidelines 3 different states can problem entry to abortion tablet mifepristone nationwide

Last updated: January 17, 2025 9:14 am
Editorial Board Published January 17, 2025
Share
SHARE

A affected person prepares to take the primary of two mixture capsules, mifepristone, for a drugs abortion throughout a go to to a clinic in Kansas Metropolis, Kan., on, Oct. 12, 2022. Credit score: AP Picture/Charlie Riedel, File

A choose in Texas dominated Thursday that three different states can transfer forward with their effort to roll again federal guidelines and make it tougher for individuals throughout the U.S. to entry the abortion drug mifepristone.

The states of Idaho, Kansas and Missouri made the request in U.S. District Courtroom in Amarillo, Texas. The one choose primarily based there’s Matthew Kacsmaryk, a nominee of former President Donald Trump who beforehand dominated in favor of a problem to the tablet’s approval.

The states need the federal Meals and Drug Administration to ban telehealth prescriptions for mifepristone and require that it’s used solely within the first seven weeks of being pregnant.

Mifepristone is normally utilized in mixture with a second drug for medicine abortion, which has accounted for greater than three-fifths of all abortions within the U.S. because the Supreme Courtroom’s 2022 ruling overturning Roe v. Wade ended the nationwide proper to abortion. Even in states the place practically all abortions are actually unlawful, girls are having abortions at comparable charges, utilizing these capsules, based on a current survey.

Abortion opponents have more and more focused abortion capsules. Beforehand, Kacsmaryk sided with a gaggle of anti-abortion docs and organizations that wished the FDA to be pressured to rescind totally its approval of mifepristone in 2000. The Supreme Courtroom ultimately dominated that these teams didn’t authorized standing to sue.

The states are pursuing a narrower problem. Fairly than goal the approval totally, they sought to undo a collection of FDA updates which have eased entry.

© 2025 The Related Press. All rights reserved. This materials will not be printed, broadcast, rewritten or redistributed with out permission.

Quotation:
A choose in Texas guidelines 3 different states can problem entry to abortion tablet mifepristone nationwide (2025, January 17)
retrieved 17 January 2025
from https://medicalxpress.com/information/2025-01-texas-states-access-abortion-pill.html

This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Over-the-counter complement might stop coronary heart illness in sort 2 diabetes sufferers

Novel imaging technique detects a number of sub-types of triple damaging breast most cancers

MRI-based technique identifies high-risk cardiac sarcoidosis sufferers who would profit from implantable defibrillators

Urinary tract an infection drug recalled

3D bioprinting is booming however patent legal guidelines could also be holding it again

TAGGED:AbortionaccessChallengejudgemifepristonenationwidepillrulesstatesTexas
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
‘Social Detonator’: In Artist’s Work, and Life, Different Classes Collide
World

‘Social Detonator’: In Artist’s Work, and Life, Different Classes Collide

Editorial Board December 11, 2021
Navy Nuclear Engineer Pleads Guilty in Submarine Espionage Case
‘Purposefully distorted’ Trump portrait to be taken down at Colorado state home after his tirade
Guardians silence Yankees’ bats after Clarke Schmidt’s early struggles
‘The Good Nurse’ | Anatomy of a Scene

You Might Also Like

Most cancers analysis in your laptop computer? New synthetic intelligence mannequin makes it attainable
Health

Most cancers analysis in your laptop computer? New synthetic intelligence mannequin makes it attainable

June 6, 2025
New strategy reverses opioid overdoses extra safely, rat examine exhibits
Health

New strategy reverses opioid overdoses extra safely, rat examine exhibits

June 6, 2025
Adopting a nutritious diet might have cardiometabolic advantages no matter weight reduction
Health

Adopting a nutritious diet might have cardiometabolic advantages no matter weight reduction

June 6, 2025
Weight problems can increase colorectal most cancers danger by 30–50%, examine finds
Health

Weight problems can increase colorectal most cancers danger by 30–50%, examine finds

June 6, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?